EBV DNA dynamics guide post-local-therapy ICI consolidation in stage II-III pulmonary lymphoepithelioma-like carcinoma. Cross-continental transportability of phase III trial results to LMIC cohort ...
A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...
In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ...
Early results of the first clinical trial to evaluate the drug invikafusp alfa (invika) in humans indicate that the treatment ...
Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be tumor-reactive, opening new avenues for immunotherapy.
Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ...
The systematic review by Mahmoudi and colleagues arrives at a moment when the field of CAR T-cell therapy is confronting a ...
Have you ever had the experience of being told, "Your white blood cell count was within the normal range" when looking at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results